Related Experiment Video
Updated: Oct 4, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53-Induced LINC00893 Regulates RBFOX2 Stability to Suppress Gastric Cancer Progression
Xinde Ou1,2, Xingyu Zhou1,2, Jin Li1,2,3
1Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Abstract:
Long noncoding RNAs (lncRNAs) have been reported to regulate diverse tumorigenic processes. However, little is known about long intergenic non-protein coding RNA 00893 (LINC00893) and its role in gastric cancer (GC). Herein we investigated its biological functions and molecular mechanism in GC. LINC00893 was decreased in GC tissues but significantly elevated in AGS cells after treatment with Nutlin-3. In GC patients, it was found that low expression of LINC00893 was correlated with tumor growth, metastasis and poor survival. Functionally, overexpression of LINC00893 suppressed the proliferation, migration and invasion of GC cells. Mechanistically, LINC00893 regulated the expression of epithelial-mesenchymal transition (EMT)-related proteins by binding to RNA binding fox-1 homolog 2 (RBFOX2) and promoting its ubiquitin-mediated degradation, thus suppressing the EMT and related functions of GC. In addition, the transcription factor p53 can regulate the expression of LINC00893 in an indirect way. Taken together, these results suggested that LINC00893 regulated by p53 repressed GC proliferation, migration and invasion by functioning as a binding site for RBFOX2 to regulate its stability and the expression of EMT-related proteins. LINC00893 acts as a tumor-inhibiting lncRNA that is induced by p53 in GC and regulates EMT by binding to RBFOX2, thus providing a novel experimental basis for the clinical treatment of GC.
Insights
Long intergenic non-protein coding RNA 00893 (LINC00893) acts as a tumor suppressor in gastric cancer (GC). It inhibits GC cell proliferation and metastasis by regulating epithelial-mesenchymal transition (EMT) via RBFOX2, offering a new target for GC treatment.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) play roles in cancer.
- The function of LINC00893 in gastric cancer (GC) is largely unknown.
Purpose of the Study:
- To investigate the biological functions and molecular mechanisms of LINC00893 in GC.
Main Methods:
- Quantitative analysis of LINC00893 expression in GC tissues and cells.
- Functional assays (proliferation, migration, invasion) upon LINC00893 manipulation.
- Mechanism studies involving RNA binding fox-1 homolog 2 (RBFOX2) and epithelial-mesenchymal transition (EMT) markers.
- Investigation of p53 regulation on LINC00893.
Main Results:
- LINC00893 expression was decreased in GC tissues and correlated with poor prognosis.
- Overexpression of LINC00893 suppressed GC cell proliferation, migration, and invasion.
- LINC00893 binds to RBFOX2, promoting its degradation and inhibiting EMT.
- p53 indirectly regulates LINC00893 expression.
Conclusions:
- LINC00893 acts as a tumor-suppressive lncRNA in GC, induced by p53.
- LINC00893 inhibits GC progression by suppressing EMT through RBFOX2 degradation.
- LINC00893 represents a potential therapeutic target for GC.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

